Yang, Hwai-I <br/><br/>
Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.  [electronic resource] 

 -  The Journal of infectious diseases  01 2020 
 - 389-399 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>1537-6613 
<br/><br/><label>Standard No.: </label>10.1093/infdis/jiz477  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Asia--ethnology<br/>Asian People<br/>Carcinoma, Hepatocellular--etiology<br/>Cohort Studies<br/>DNA, Viral--genetics<br/>Data Accuracy<br/>Female<br/>Hepatitis B virus--genetics<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Liver Neoplasms--etiology<br/>Male<br/>Middle Aged<br/>Proportional Hazards Models<br/>ROC Curve<br/>Random Allocation<br/>Research Design<br/>Risk Assessment